Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
IEEE Trans Cybern ; 52(7): 7187-7195, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33449902

RESUMEN

This article investigates input-to-state stability (ISS) and integral ISS (iISS) of nonlinear impulsive systems based on the event-triggered impulsive control (ETIC) strategy, where the impulse sequence is generated by some predesigned event conditions. Unlike traditional event-triggered control, ETIC means that the controller is activated only when some state-dependent event conditions are triggered and moreover, there is not any control transmission between two consecutive triggered impulse instants. Event-triggered impulses are usually regarded as a class of state-dependent impulses, where the event-triggered mechanism (ETM) is an impulse generator. By using the ETIC strategy, some Lyapunov-based criteria are established, which can effectively avoid infinitely fast triggering behavior and guarantee ISS/iISS of nonlinear impulsive systems. Then, the theoretical results are applied to nonlinear system, where a class of ETMs and impulsive control gain are derived with the help of LMIs. Finally, two numerical examples are presented to illustrate the validity of our control strategies.

2.
Vet Immunol Immunopathol ; 162(3-4): 122-31, 2014 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-25467888

RESUMEN

Florfenicol (FLO) is a broad-spectrum antibacterial agent for treatment of bacteriosis of piglets in veterinary practice. To study the toxicity to the hematopoietic and lymphoid organs of piglets treated with a therapeutic dose of FLO, 20 healthy weaned piglets were selected and randomly divided into two groups. Piglets in the FLO group were fed with fodder supplemented with 30mg/kg BW of FLO twice a day for 10 days. Blood samples were drawn at four time points: 1 day before FLO administration and 1, 7, and 14 days post-withdrawal. Three or four piglets were euthanized at each time point post-withdrawal and tissue samples (bone marrow, thymus and spleen) were collected for fixation and cryostorage. The levels of classical swine fever virus (CSFV) antibody against the vaccine, the concentrations of Hsp70 and IL-6 in serum and Hsp70 in tissues, and the mRNA expression levels of B-cell lymphoma 2 (bcl-2) and tumor suppressor p53 were detected, the hematology of the piglets were analyzed, and the histopathology and the status of apoptosis of the hematopoietic and lymphoid organs was examined. The results showed changes in several indicators in the FLO group 1 day post-withdrawal: the concentration of red blood cells (RBCs) was decreased, and that of platelets (PLTs) was significantly lower (p<0.05); the volumes of RBC and PLT were increased; the sum of blood lymphocytes was statistically decreased (p<0.05); the concentration of IL-6 was significantly increased (p<0.05); the concentrations of Hsp70 in serum and tissues were increased; obvious atrophy of the hematopoietic cell lines and partial replacement by fat cells were observed in bone marrow; thymus and spleen tissues showed lower concentrations and sparser arrangement of lymphocytes in the thymic medulla and white pulp of the spleen respectively; and the mRNA expression levels of bcl-2 in the three tissues were up-regulated, while that of p53 was down-regulated. With time after cessation of FLO administration, the indicators of the FLO group gradually returned to close to that of the control group and the histological lesions of the tissues gradually recovered, and the differences in the densities of lymphocytes and cell arrangements in the tissues between two groups gradually decreased. In conclusion, a therapeutic dose of FLO induces temporary toxicity in the hematopoietic and lymphoid organs of piglets to some extent, and influences hemopoiesis and immune function. These effects gradually decrease after cessation of FLO administration.


Asunto(s)
Médula Ósea/inmunología , Bazo/inmunología , Porcinos/inmunología , Tianfenicol/análogos & derivados , Timo/inmunología , Animales , Recuento de Células Sanguíneas/veterinaria , Proteínas HSP70 de Choque Térmico/sangre , Histocitoquímica/veterinaria , Etiquetado Corte-Fin in Situ/veterinaria , Interleucina-6/sangre , Proteínas Proto-Oncogénicas c-bcl-2/análisis , ARN/química , ARN/genética , Distribución Aleatoria , Reacción en Cadena en Tiempo Real de la Polimerasa/veterinaria , Tianfenicol/administración & dosificación , Tianfenicol/efectos adversos , Tianfenicol/farmacología , Proteína p53 Supresora de Tumor/análisis
3.
Cell Mol Neurobiol ; 25(8): 1171-83, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16388330

RESUMEN

Neuronal degeneration and astrogliosis are hallmarks of prion disease. Synthetic prion protein (PrP) peptide 106-126 (PrP106-126) can induce death of neurons and proliferation of astrocytes in vitro and this neurotoxic effect depends on the expression of cellular PrP (PrPC) and is hence believed to be PrP(C) -mediated. To further elucidate the involvement of PrPC in PrP106-126-induced neurotoxicity, we determined the expression of PrP mRNA in primary culture of rat cortical neuron cells, cerebellar granule cells, and astrocytes following treatment with 50 microM of PrP106-126 scrambled PrP106-126 by quantitative real-time RT-PCR. As shown by MTT test, PrP106-126 induced significant death of neuron cells and marked proliferation of astrocytes after 10 days of treatment. Under the same treatment regimens, the level of PrP gene expression was significantly down-regulated in cortical neuron cell cultures and cerebellar granule cell cultures and was up-regulated in astrocyte cultures. The altered PrP gene expression occurred as early as 3 days after the treatment. After 10 days of treatment, while the cultured cortical neurons underwent further apoptosis, their expression of PrP gene started to recover gradually. These findings indicate that PrP 106-126 regulates transcription of the PrP gene and this activity is associated with its neurotoxicity in primary rat neuronal cultures.


Asunto(s)
Astrocitos/metabolismo , Regulación de la Expresión Génica/fisiología , Neuronas/metabolismo , Neurotoxinas/toxicidad , Fragmentos de Péptidos/toxicidad , Proteínas PrPC/genética , Priones/toxicidad , Animales , Animales Recién Nacidos , Apoptosis/efectos de los fármacos , Apoptosis/genética , Astrocitos/efectos de los fármacos , Astrocitos/patología , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Corteza Cerebelosa/efectos de los fármacos , Corteza Cerebelosa/metabolismo , Corteza Cerebelosa/fisiopatología , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Corteza Cerebral/fisiopatología , Técnicas de Cocultivo , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/genética , Regulación de la Expresión Génica/efectos de los fármacos , Gliosis/inducido químicamente , Gliosis/genética , Gliosis/metabolismo , Degeneración Nerviosa/inducido químicamente , Degeneración Nerviosa/genética , Degeneración Nerviosa/metabolismo , Neuronas/efectos de los fármacos , Neuronas/patología , Fragmentos de Péptidos/genética , Proteínas PrPC/biosíntesis , Enfermedades por Prión/genética , Enfermedades por Prión/metabolismo , Enfermedades por Prión/fisiopatología , Priones/genética , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA